TransCode Therapeutics Goodwill and Intangible Assets 2021-2025 | RNAZ

TransCode Therapeutics goodwill and intangible assets from 2021 to 2025. Goodwill and intangible assets can be defined as the sum of all intangible asset fields

TransCode Therapeutics Goodwill and Intangible Assets 2021-2025 | RNAZ

TransCode Therapeutics goodwill and intangible assets from 2021 to 2025. Goodwill and intangible assets can be defined as the sum of all intangible asset fields
Related Stocks
Company NameMarket
Cap
Chugai Pharmaceutical (CHGCY)$69.3B
Zoetis (ZTS)$67.6B
Takeda Pharmaceutical (TAK)$47B
Daiichi Sankyo, - (DSNKY)$46.1B
BeOne Medicines - (ONC)$33.7B
Sandoz Group AG (SDZNY)$26.1B
Summit Therapeutics (SMMT)$20B
Merck (MKKGY)$16.8B
Shionogi (SGIOY)$15.5B
United Therapeutics (UTHR)$14B
Neurocrine Biosciences (NBIX)$13.1B
Orion OYJ (ORINY)$10.8B
IPSEN (IPSEY)$10.6B
Madrigal Pharmaceuticals (MDGL)$8.3B
Corcept Therapeutics (CORT)$7.7B
Grifols, S.A (GRFS)$7.3B
Ionis Pharmaceuticals (IONS)$6.9B
Stevanato Group S.p.A (STVN)$6.8B
Hikma Pharmaceuticals Plc (HKMPF)$5.3B
Ono Pharmaceutical (OPHLF)$5.1B
Soleno Therapeutics (SLNO)$4.3B
AMNEAL PHARMACEUTICALS, INC (AMRX)$2.9B
NewAmsterdam Pharma (NAMS)$2.9B
Crinetics Pharmaceuticals (CRNX)$2.8B
Hypermarcas (HYPMY)$2.7B
Catalyst Pharmaceuticals (CPRX)$2.5B
Centessa Pharmaceuticals (CNTA)$2.3B
Ocular Therapeutix (OCUL)$2.2B
Endo (NDOI)$1.8B
BioCryst Pharmaceuticals (BCRX)$1.8B